0\" encoding=\"UTF-8\"?>\n<table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"center\" valign=\"middle\" style=\"border-top:solid thin;border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Name</th><th align=\"center\" valign=\"middle\" style=\"border-top:solid thin;border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Sponsor/Developer</th><th align=\"center\" valign=\"middle\" style=\"border-top:solid thin;border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Mechanism of Action</th><th align=\"center\" valign=\"middle\" style=\"border-top:solid thin;border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Indication</th></tr></thead><tbody><tr><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Afrezza</td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">MannKind</td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Ultra-rapid-acting mealtime insulin therapy</td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Adults with type 1 or type 2 diabetes</td></tr><tr><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Albiglutide </td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">GlaxoSmithKline</td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Glucagon-like peptide (GLP) 1 agonist</td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Once weekly for adults with type 2 diabetes</td></tr><tr><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Aleglitazar </td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Roche</td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Dual peroxisome proliferator-activated receptor (PPAR) alpha/gamma activation</td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Cardiovascular risk reduction in type 2 diabetes</td></tr><tr><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Alogliptin, Alogliptin and pioglitazone, Alogliptin and metformin </td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Takeda Pharmaceuticals and Furiex Pharmaceuticals</td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">DPP-4 inhibitor</td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Oral treatment of type 2 diabetes, individually and in two fixed-dose combinations</td></tr><tr><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Atrasentan</td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">AbbVie</td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Selective endothelin-A receptor antagonist</td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Oral once-daily treatment for diabetic nephropathy</td></tr><tr><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Dulaglutide (LY2189265)</td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Eli Lilly</td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">GLP-1 analog</td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Once weekly for type 2 diabetes</td></tr><tr><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Empagliflozin (BI10773)</td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Boehringer Ingelheim and Eli Lilly</td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Sodium dependent glucose transporter 2 (SGLT2) inhibitor</td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Oral treatment for adults with type 2 diabetes</td></tr><tr><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Ertugliflozin (MK-8835; PF-04971729)</td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Merck &amp; Co.